The fatty acid synthase-I and fatty acid synthase-II pathways producing mycolic acids are linked by the beta-ketoacyl-( acyl-carrier-protein ) synthase III enzyme, often designated as mtFabH . Novel inhibitors of this enzyme could potentially be used as therapeutic agents.